ONTRUZANT

Google image searchProduct monograph

Active ingredient

trastuzumab, 440 MG/VIAL

DIN: 02524325

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: MULTIPLE USE VIAL

Schedule: Prescription / Schedule D

Company: SAMSUNG BIOEPIS CO., LTD

Date: 20-JUL-2022

ATC:

Reference brand drug: Herceptin

Pharmaceutical standard: MFR

Search on Google